Hereditary tyrosinemia type-1
Also known as: Hereditary tyrosinemia type 1 / Tyrosinemia type I / Tyrosinemia, Type I / Fumarylacetoacetase deficiency, acute type (disorder) / Tyrosinemia type I (disorder) / Hereditary hypertyrosinemia (disorder) [Ambiguous] / Fumarylacetoacetase deficiency (disorder) / Tyrosinaemia type I / Ganglion-blocking drug adverse reaction (disorder) / Deficiency of fumarylacetoacetase (disorder) / Tyrosinaemia / Tyrosinemia (disorder) / Tyrosinemias / Hypertyrosinemia / Tyrosinemia
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00348 | Nitisinone | A hydroxyphenylpyruvate dioxygenase inhibitor used as an adjunct to dietary restrictions for the treatment of hereditary tyrosinemia type 1 (HT-1), which causes intolerance to tyrosine containing foods. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00348 | Nitisinone | 4-hydroxyphenylpyruvate dioxygenase | target |
| Drug | Drug Name | Phase | Status | Count |
|---|